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Epithelial–mesenchymal transitionCurrent evidence suggests a prominent role for endoplasmic reticulum (ER) stress and activation of the
unfolded protein response (UPR) in ﬁbrotic conditions affecting a number of internal organs, including the
lungs, liver, GI tract, kidney, and heart. ER stress enhances the susceptibility of structural cells, in most cases
the epithelium, to pro-ﬁbrotic stimuli. Studies suggest that ER stress facilitates ﬁbrotic remodeling through acti-
vation of pro-apoptotic pathways, induction of epithelial–mesenchymal transition, and promotion of inﬂamma-
tory responses. While genetic mutations that lead to ER stress underlie some cases of ﬁbrosis, including lung
ﬁbrosis secondary to mutations in surfactant protein C (SFTPC), a variety of other factors can cause ER stress.
These ER stress inducing factors include metabolic abnormalities, oxidative stress, viruses, and environmental
exposures. Interestingly, the ability of the ER to maintain homeostasis under stress diminishes with age, poten-
tially contributing to the fact that ﬁbrotic disorders increase in incidence with aging. Taken together, underlying
ER stress and UPR pathways are emerging as important determinants of ﬁbrotic remodeling in different forms of
tissue ﬁbrosis. Further work is needed to better deﬁne themechanisms bywhich ER stress facilitates progressive
tissue ﬁbrosis. In addition, it remains to be seen whether targeting ER stress and the UPR could have therapeutic
beneﬁt. This article is part of a Special Issue entitled: Fibrosis: Translation of basic research to human disease.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
In addition to its role in neurodegenerative diseases and diabetes,
endoplasmic reticulum (ER) stress is emerging as a factor in a variety of
diseases that result in ﬁbrotic remodeling of internal organs, including
liver, gastrointestinal (GI) tract, kidneys, heart, and lungs [1–7]. The
ER is an important intracellular organelle whose tasks include facilitat-
ing the conversion of nascent proteins to functional forms. Conditions
such as calcium depletion, glucose or nutrient deprivation, viral infec-
tions, environmental exposures, aging, or expression ofmutant proteins
can alter the functionality of the ER, resulting in ER stress. To maintain
homeostasis, cells rely on protective mechanisms to help them cope
with ER stress, pathways referred to collectively as the unfolded protein
response (UPR). The UPR encompasses three transmembrane proteins
that act as sensors of ER stresswith activation of downstreampathways
orchestrating a cascade of events that have evolved to protect the cell
[1]. Cells with high metabolic activity or with high secretory function
rely on the UPR pathways to maintain homeostasis in the setting of ERs: Translation of basic research
ary and Critical Care Medicine,
N, Nashville, TN 37232–2650,
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l rights reserved.stress. Perhaps this is best illustrated in the function of plasma cells,
which rely on a highly functioning UPR to maintain homeostasis in
the setting of immunoglobulin production. However, when ER stress
is severe or prolonged, cellular dysfunction can ensue, resulting in inju-
ry or death, inﬂammatory signaling, and/or phenotype transition. This
review focuses on structural cells, primarily epithelial cells, where evi-
dence indicates that ER stress can enhance vulnerability to injury and
facilitate ﬁbrotic remodeling in a variety of tissues. Although the mech-
anisms linking ER stress and ﬁbrosis are incompletely understood, we
will discuss the current state of knowledge regarding the contribution
of ER stress and the UPR to cellular dysfunction and ﬁbrosis.
2. Endoplasmic reticulum stress and the unfolded protein response
The endoplasmic reticulum (ER) is an organelle found in all eu-
karyotic cells. It is crucially involved in protein folding, lipid synthesis,
glycogen production and storage, and calcium metabolism [1]. Under
normal physiological conditions, chaperone proteins assist in folding
of nascent proteins, thereby preventing aggregation of proteins in
the ER. Immunoglobulin heavy-chain-binding protein (BiP), also re-
ferred to as glucose regulated protein 78 (GRP78), is an important
chaperone that is typically increased when ER stress is encountered.
In fact, upregulation of BiP can serve as an indicator of ER stress
[8–10]. BiP binds to transmembrane sensor protein PKR-like endo-
plasmic reticulum Kinase (PERK), activating transcription factor 6
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inactive state [11]. With protein accumulation in the ER, BiP interacts
with these nascent proteins and is released from these transmembrane
sensors. Once unbound from BiP, these three transmembrane proteins
can then assume their activated state, leading to the cascade of events
known as the UPR (Fig. 1). PERK and IRE-1 are activated by phosphory-
lation while ATF6 is activated by proteases. These UPR proteins then
act to maintain homeostasis and normal functioning of the ER and the
cell through attenuating protein translation, increasing cytoprotective
factors, enhancing production of folding chaperone proteins, and
up-regulating expression of pro-degradation factors (Fig. 1) [12,13].
However, when these UPR mechanisms fail or when the UPR is
hyperactivated, apoptotic cell death can occur [14].
Activation of PERK occurs by trans auto-phosphorylation and dimer-
ization. Activated PERK phosphorylates the α-subunit of eukaryotic
translational initiation factor 2 (peIF2α), which hinders global protein
synthesis [15]. The importance of PERK in cell survival in the setting of
ER stress was established by studies in which cells with mutant PERK
were shown to be unable to phosphorylate eIF2α, leading to increased
sensitivity to induction of ER stress and greater cell death [16]. In addi-
tion to inhibition of protein translation, peIF2α induces the expression
of ATF4, which has been shown to increase expression of protective
redox proteins as well as the pro-apoptotic protein CCAAT/enhancer
binding protein (EBP) homologous protein (CHOP) [17]. As a result, a
delicate balance appears to dictate whether phosphorylated eIF2α de-
pendent mechanisms are pro- or anti-apoptotic [15–17]. Along theseP
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Fig. 1. Schematic illustration of ER stress and the UPR. ATF=activating transcription factor; B
α-mannosidase-like protein; eIF2α=eukaryotic initiation factor 2α; ER=endoplasmic reti
enzyme 1 (IRE-1); PERK=PKR-like ER kinase; XBP1=X-box binding protein 1; GADD34=
GRP94=glucose-regulated protein 98; CHOP=C/enhancer binding protein (EBP) homol
kinases; S1P=site-1 protease; S2P=site-2 protease; RIDD=regulated IRE1-dependent declines, cells from ATF4 knockout mice are more sensitive to oxidative
damage [16,18].
ATF6 is an important component of the UPR pathways and has been
implicated in several diseases. When activated by ER stress, ATF6 trans-
locates to the golgi, where it is cleaved by site1 and site2 proteases into
an NH2 terminal domain and a cytosolic domain. The cleaved cytosolic
domain is then transported into the nucleus where it activates the tran-
scription of several ER proteins such as BiP, X-box binding protein 1
(XBP1), GRP94, calreticulin, calnexin, protein disulﬁde isomerase (PDI),
and CHOP [10,19–21]. ATF6 has two isoforms — ATF6α and ATF6β. Of
the two isoforms, ATF6α has been shown to be most important for cell
survival under ER stress. Double knockouts of ATF6α and ATF6β results
in embryonic lethality while single gene deletion of ATF6α or ATF6β
does not result in an obviously abnormal phenotype. However, when
ATF6α knockout mice are challenged with intraperitoneal injection of
the ER stress inducing agent tunicamycin, survival of mice is reduced
compared to wild type controls [22].
IRE-1 is a transcription factor in the UPR pathway and its importance
in the UPR is well established in studies from mammalian cells. It exist
in two isoforms— IRE-1α and IRE-1β. When activated, IRE-1 undergoes
dimerization, with the RNase domain of IRE-1 cleaving XBP1 into its
spliced (and active) form. Spliced XBP1 acts as a transcription factor
and promotes the transcription of ER associated degradation (ERAD)
target genes such as ER degradation enhancing α-mannosidase-like
protein (EDEM) [23,24]. Knockouts of IRE-1 and XBP1 are embryonic
lethal with defects in liver development. Intestinal epithelial speciﬁcα
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Together, these studies suggest a protective effect of XBP1 in liver
and intestine. Recent studies also indicate a prominent role for IRE-1
in cell death associated with chronic ER stress. Prolonged exposure of
both primary mouse β-cells and rat insulinoma cell line (INS-1) to glu-
cose results in increased expression of IRE-1α, leading to insulin mRNA
degradation and apoptosis [27]. IRE-1α degrades mRNAs encoding
membrane bound and secretory proteins through a mechanism called
regulated IRE-1-dependent decay (RIDD) [28,29]. In studies by Han
et al. in INS-1 cells [30], the RNase domain of IRE-1 was shown to func-
tion not only by generating the protective spliced form of XBP1, but also
by mRNA degradation and effects on cell survival independent of XBP1
splicing. Thus, IRE-1 pathway activation may improve cell survival, but
can also contribute to cell death in situations of chronic ER stress.
An important mechanism by which accumulated unfolded proteins
in the ER are eliminated is through the ERAD pathway. Both ATF6 and
IRE-1 pathways play a role in the ERAD pathway as ATF6 and IRE-1
knockoutmice both showdefects in the ability to activate ERAD compo-
nents [19,31–33]. In addition to ERAD, cells can also eliminate proteins
that accumulate in the ER through activation of autophagy, which is a
catabolic process mediated through the lysosomal pathway [34,35].
However, it is not clear whether ER stress mediated autophagy protects
cells from undergoing apoptosis, as some data suggest that it also in-
duces cell death [36–38].
When a cell encounters prolonged ER stress or is overloaded
with accumulation of proteins in the ER, cell death pathways such as
caspase-4 (and its murine homolog caspase-12), CHOP, and c-Jun
NH2-terminal kinase (JNK) are activated [1,39–41]. Caspase-4 is found
in the ER membrane, providing a direct link between ER stress and
activation of the caspase pathway [39]. CHOP is also a major regulator
of cell death under ER stress. In vitro overexpression of CHOP results
in apoptosis, while deﬁciency of CHOP protects cells from apoptosis
[42,43]. However, apoptosis can be induced in CHOP knockout mice
after exposure to ER stress inducing agents, indicating that CHOP inde-
pendent pathways are also important in ER stress associated cell death.
3. Pulmonary ﬁbrosis
Idiopathic pulmonary ﬁbrosis (IPF) is the most common and severe
of the idiopathic interstitial pneumonias with a mortality rate greater
than 50%within 3 years of diagnosis [44]. Over the past decade,multiple
lines of evidence have indicated a role for ER stress in the pathogenesis
of IPF and its familial form, known as familial interstitial pneumonia
(FIP). Initial insights into the role of ER stress in IPF came from the obser-
vation that mutations in the gene encoding surfactant protein C (SFTPC)
were associated with FIP in both children and adults [45,46]. Type II al-
veolar epithelial cells (AECs) secrete surfactant protein C (SP-C), a highly
hydrophobic protein, into the alveolar space [45,46]. Because of its
marked hydrophobicity, SP-C must be processed through the ER as a
pro-protein, with subsequent cleavage steps in the secretory pathway
yielding the mature protein that is secreted into the alveolar space
[47,48]. Folding of the carboxy-terminal region of the pro-protein occurs
in the ER, and mutations in this region of the gene result in a protein
product that is misfolded, leading to protein accumulation and ER stress
[6,49]. In 2008, we evaluated human lung tissues samples from FIP
patients with a mutation in SFTPC (L188Q), FIP patients without SFTPC
mutations, and sporadic IPF patients for expression of BiP, EDEM and
XBP1 [6]. These ER stress markers were prominently expressed in
AECs lining areas of ﬁbrosis in patients with SFTPC mutations as well
as patients with lung ﬁbrosis in the absence of SFTPCmutations. Subse-
quently, Korfei et al. reported thatAECs lining areas ofﬁbrosis in IPF lung
tissue sections not only had expression of ER stress markers, but these
same cells also had activation of pro-apoptotic pathways [7].
In vitro studies in which carboxy-terminal SFTPC mutations are
expressed in lung epithelial cell lines revealed mutant protein accu-
mulation in the ER, leading to ER stress and UPR pathway activation[6,49–51]. Similar to SFTPC, mutations in the gene encoding surfactant
protein A2 (SFTPA2) have been linked to cases of FIP [52]. Modeling of
these SFTPA2 mutations in vitro suggests that the resultant mutant
proteins cause ER stress and UPR pathway activation [52,53].
Recently, we developed a mouse model in which the L188Q SFTPC
mutation is inducibly expressed in type II AECs [51]. Such expression
leads to ER stress in the type II AEC population, but these cells are able
to maintain homeostasis in the setting of ER stress without the devel-
opment of lung ﬁbrosis. However, following low dose bleomycin,
these mice develop excessive lung ﬁbrosis. In a separate model, we
induced ER stress in the lungs of wild type mice by intratracheal ad-
ministration of tunicamycin. As with mutant SFTPC expression, ER
stress alone did not cause lung ﬁbrosis, but did predispose to greater
bleomycin induced ﬁbrosis [54]. Taken together, these studies suggest
that ER stress leads to a vulnerable AEC population with predisposi-
tion to ﬁbrosis after injury.
Of the potentialmechanisms linking ER stress to ﬁbrosis in the lungs,
induction of apoptosis is the best characterized. Increased apoptosis is
observed in lung epithelial cell lines when mutant forms of SFTPC
(Δexon4 and L188Q SFTPC) are expressed, with studies revealing this
process is partially mediated through a caspase-4 (caspase-12) mecha-
nism [6,49,50]. In vivo, transgenic mice expressing the Δexon4 SFTPC
mutation under the human SFTPC promoter had abnormal branching
morphogenesis in the lung, with evidence supporting a prominent
role for protein misfolding and abnormal surfactant protein processing,
as well as lung epithelial cell apoptosis [55]. In our model in which
we conditionally expressed mutant L188Q SFTPC exclusively in type
II AECs, these mice did not have increased AEC apoptosis with trans-
gene expression alone; however, when challenged with a low dose
of bleomycin, L188Q SFTPC expressing mice had greater AEC death
as detected by TUNEL staining, along with evidence of increased
caspase-12 and caspase-3 activation [54].
Another mechanism through which ER stress in epithelial cells may
contribute to ﬁbrosis is through shift to a mesenchymal phenotype.
Hepatocytes, kidney tubular epithelial cells, and AECs have all been
described to undergo epithelial–mesenchymal transition (EMT) under
pathological conditions [56–58]. A relationship between ER stress and
epithelial cell plasticity was ﬁrst demonstrated in thyroid epithelial
cells where induction of ER stress via tunicamycin administration led
to EMT [59]. Consistent with this ﬁnding, we and others have shown re-
cently that induction of ER stress in lung epithelial cells, either through
expression ofmutant SFTPC or following exposure to tunicamycin, leads
to EMT via Src and Smad signaling [51,60]. Further, we showed that this
mechanism is likely mediated primarily through IRE-1α signaling [51].
Recently, a study by Baek et al. revealed that UPR activation may also
be involved in myoﬁbroblast differentiation of lung ﬁbroblasts [61],
extending this potential association between ER stress and cellular
plasticity.
Taken together, multiple lines of evidence implicate ER stress in
the AEC population as having a prominent role in the pathogenesis
of IPF. Interestingly, however, mouse modeling suggests that induc-
tion ER stress alone is not sufﬁcient for the development of ﬁbrosis,
but when present, ER stress generates an AEC population that is
vulnerable to the effects of additional injurious stimuli.
4. Liver ﬁbrosis
Liver ﬁbrosis is seen in many types of chronic liver diseases [62].
ER stress pathway components have been observed in several forms
of liver diseases [63]. Alpha 1-antitrypsin deﬁciency is a genetic disor-
der caused by defective production of α1-antitrypsin (α1AT), with
lung manifestations in adults and liver disease in adults and children
[64]. Liver disease manifestations result from hepatocyte accumula-
tion of a mutant form of α1AT with resultant ER stress. ER stress path-
way components BiP and CHOP have been noted to be markedly
increased in experimentally induced liver ﬁbrosis in transgenic mice
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tant protein accumulates in the ER of hepatocytes, suggesting that ER
stress sensitizes hepatocytes to injury and ﬁbrosis. Furthermore, studies
in liver cells demonstrate both proteosome and non-proteosomal path-
ways are activated to degrade the α1AT accumulated in the ER of liver
cells [12].
In another model, liver ﬁbrosis and acute liver injury were greatly at-
tenuated in CHOP deﬁcient mice following bile duct ligation [2,65–67].
Transforming growth factor β1 (TGFβ1) is a potent proﬁbrotic cytokine
secreted bymanydifferent cells [68,69], and its expressionwas complete-
ly abolished in CHOP deﬁcient mice [2,64]. Similarly,αSMA expression, a
marker of myoﬁbroblasts, was markedly decreased in CHOP deﬁcient
mice [2,67]. More recently, Mu et al. [3], using a rat model of ﬁbrosis in-
duced by methionine–choline-deﬁcient diet (MCDD), demonstrated
that ER stress markers, such as BiP and PDI, were markedly enhanced in
rats fed with MCDD compared to those fed a control diet [3]. In addition,
αSMA, TGFβ1, and collagen were increased in MCDD fed rats. Both
ER stress and ﬁbrosis were reversed when MCDD fed rats were given a
normal diet.
When ER stress was induced in primary hepatocytes by exposure
to fatty acids, CHOP expression was found to be up-regulated [67].
SiRNA knock down of CHOP in a hepatocyte cell line protected these
cells from apoptosis when challenged with the ER stress inducing
agent thapsigargin and this protective effect was mediated via inhibi-
tion of the JNK pathway [67]. Similarly, hepatocytes from CHOP null
mice had reduced apoptosis when exposed to toxic stimuli such as
glycochenodeoxycholic acid or intragastric ethanol feeling [2,66,67].
Taken together, these studies suggest that the ER stress pathway con-
tributes to genetic and injury-induced models of hepatic ﬁbrosis and
that CHOPmay be an important player in liver ﬁbrosis through effects
on hepatocyte survival.
5. Inﬂammatory bowel disease
Intestinal ﬁbrosis results from chronic inﬂammation in the patho-
genesis of Crohn's disease (CD) and ulcerative colitis (UC), the two
prominent forms of inﬂammatory bowel disease (IBD) [70]. Several
studies strongly correlate ER stress with inﬂammation in IBD. Analy-
sis from human biopsy samples with CD and UC demonstrated that
BiP mRNA expression and XBP1 splicing are markedly increased not
only in inﬂamed mucosa but also in areas of mucosa without inﬂam-
mation, suggesting that ER stress might be a common underlying
abnormality in IBD [25]. In the dextran sodium sulphate (DSS) colitis
model, IRE-1β knockout mice developed more severe colitis com-
pared to wild type controls as measured by inﬁltration of mononucle-
ar leukocytes on tissue sections and prominent immunostaining
for Intercellular Adhesion Molecule 1 (ICAM-1) in the mucosa of the
distal colon. Consistent with these ﬁndings, it was recently demon-
strated that intestinal epithelial cell speciﬁc deletion of XBP1 resulted
in spontaneous inﬂammation with increased levels of tumor necrosis
factor α (TNFα) as well as polymorphonuclear cell inﬁltrates in the
small intestine (but interestingly not in the colon), which were ac-
companied by paneth cell apoptosis mediated via the JNK pathway.
Interestingly, ER stress markers BiP and CHOP were also markedly
increased in these mice [25,26]. The role of ER stress in intestinal in-
ﬂammation is well documented in mice with mutations in the Muc2
gene. Muc2 is a component of mucin secreted by goblet cells in the
small and large intestine. Heazelwood et al. generated two strains of
mice with a missense mutation in Muc2 using chemical mutagenesis
[71]. In both mice strains, Muc2 protein accumulated in the ER with
concomitant increased BiP expression and increased XBP1 splicing
in the intestinal epithelium. These mice developed spontaneous
inﬂammation in the large intestine and supernatants from explant
cultures of distal colon from these mice had increased inﬂammatory
cytokines such as interleukin-1β (IL-1β), TNF-α, and interferon-γ
(IFN-γ) compared to wild type controls. Thus, multiple avenues ofinvestigation implicate ER stress as having a key role in the pathogen-
esis of IBD, likely through effects on inﬂammation and apoptosis of
epithelial cells.
6. Renal ﬁbrosis
Tubular interstitial injury is a major cause of chronic kidney dis-
eases [72], and the role of ER stress in kidney ﬁbrosis has been ex-
plored recently. Kimura et al. [73] developed mutant mice in which
BiP does not have the carboxyl terminal Lys-Asp-Glu-Leu (KDEL) ER
retention sequence that functions to retain BiP in the ER lumen. Inter-
estingly, homozygous mice died a few hours after they were born
with defects in surfactant protein C synthesis and respiratory failure
[74,75]. Heterozygous mice, however, developed renal ﬁbrosis and
tubular atrophy with age [73].
In the kidney, apoptosis, and EMT have been associated with
ER stress. Apoptosis has been noted in tubular epithelial cells in
animal models of albumin proteinuria, puromycin aminonucleoside
nephropathy, and cyclosporine induced nephropathy, with in vitro
models suggesting this effect is mediated via CHOP [76,77]. Further-
more, using the unilateral ureteral obstruction rat model, Chiang et
al. showed that tubular epithelial cells have evidence of ER stress
with subsequent apoptosis through activation of the JNK pathway,
culminating in ﬁbrosis [4]. Proximal renal tubular epithelial cells
have also been noted to differentiate into a mesenchymal phenotype
under ER stress induced by cyclosporine, with both TGFβ dependent
[78] and TGFβ independent signaling [79], potentially contributing
to ﬁbrosis. Thus, based on experimental evidence to date, the impact
of ER stress on kidney ﬁbrosis appears to be prominently mediated
through regulation of cell survival and plasticity, ﬁndings which are
similar to those observed in pulmonary ﬁbrosis.
7. Cardiac ﬁbrosis
In the heart, ER stress and the UPR pathway are activated in several
disease models resulting in cardiac remodeling and ﬁbrosis. ER stress
markers BiP, PDI and CHOP were found to be up-regulated in a rat
model of cardiac ﬁbrosis induced by subcutaneous injection of isopro-
terenol. Treatment with the chemical chaperone 4-phenylbutyric acid
(4-PBA) not only prevented expression of BiP, PDI and CHOP, but also
attenuated cardiac ﬁbrosis in this model [5,80]. In anothermodel of car-
diac ﬁbrosis induced by angiotensin II, Kassan et al. showed that ATF4,
peIF2α, and CHOP were up-regulated, along with increased levels of
TGFβ1, Smad signaling, and collagen I expression. Interestingly the
chemical chaperone 4-PBA attenuated cardiac ﬁbrosis, as well as TGβ1
expression and Smad signaling [81]. These ﬁndings show that ER stress
in cardiac myocytes affects ﬁbrotic remodeling, but further work is
needed to identify the mechanisms involved. Unlike other organs
where ER stress in the epithelium appears important in ﬁbrotic dis-
eases, these studies highlight the potential importance of ER stress in
other cell types with high metabolic activity and suggest that ER stress
in these cells could also render them vulnerable to ﬁbrotic stimuli.
8. Potential causes of ER stress in ﬁbrosis
While genetic causes of ER stress have provided important insights
into the connection between ER stress andﬁbrosis, the genetically deter-
mined expression of misfolded proteins appears to be a rare cause of
organ ﬁbrosis. For example, while ER stress pathways are commonly
activated in IPF, only a very small proportion of these cases are related
to misfolded proteins resulting from SFTPC mutations. Likewise,
misfoldedα1AT underlies only a small proportion of liver ﬁbrosis. How-
ever, several other factors that induce ER stress have been identiﬁed that
could be relevant to ﬁbrosis [8,82–84].
Viral infections can result in ER stress and UPR pathway activation
related to viral protein synthesis with subsequent processing through
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result in activation of the UPR pathway [85,86]. In the lung, herpesvi-
ruses, most notably Epstein Barr Virus (EBV) and cytomegalovirus
(CMV), can be found in epithelial cells lining the areas of ﬁbrosis, a pat-
ternwhich is not observed in normal lung tissue controls [6,7]. Interest-
ingly, herpesviruses are known to activate UPR pathways [8], and we
have shown that herpesvirus antigens colocalizewith ER stressmarkers
in the hyperplastic epithelium in areas of lung ﬁbrosis [6]. In addition, a
recent study showed that old mice infected with murine γ-herpesvirus
68 develop lung ﬁbrosis, possibly through an ER stress related mecha-
nism [87]. Taken together, these available data suggest that viral infec-
tions may be involved in the pathogenesis of ﬁbrosis through ER stress
induction and activation of the UPR.
Oxidative stress is another stimulus that can enhance expression
of UPR pathway components [88] and appears to have a role in ﬁbro-
sis of different organs [89–91]. In addition to the usual effects of ER
stress, induction of the UPR by reactive oxygen species can result in
activation of Nrf2, which is an important transcription factor involved
in induction of Phase 2 enzymes that detoxify carcinogens and oxi-
dants. Activated PERK phosphorylates Nrf2, which is an alternative
means to activate this transcription factor [92]. In Nrf2 deﬁcient
mice, cyclosporine A treatment induces greater ER stress and renal ﬁ-
brosis compared to wild type mice with increased expression of
αSMA and TGFβ [93].
Environmental exposure to airborne particulates and cigarette
smoke has been shown to cause ER stress. Airborne particulates,
which have been linked to some forms of pulmonary ﬁbrosis [94], ac-
tivate several pro-ﬁbrotic intracellular signaling pathways [95]. In aVulnerable
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Fig. 2. Schematic of proposed mechanisms by which ER stressrecent study using both in vitro cell culture and an in vivo mouse
model, Laing et al. demonstrated that airborne particulate matter
up-regulates PERK and IRE1α pathways with resultant CHOP mediat-
ed apoptosis in both lung and liver cells. Similarly, particulate matter
was also shown to induce expression of ATF4 in bronchial epithelial
cells [83,96]. Cigarette smoke exposure up-regulates UPR related
genes in both normal and malignant lung epithelial cells [82]. Fur-
thermore, UPR pathways are activated in 3 T3 ﬁbroblasts following
exposure to aqueous extract of cigarette smoke [97,98]. Currently,
the role and importance of ER stress in mediating the long-term
effects of airborne particulates and cigarette smoke in humans are
unknown.
In addition to environmental stimuli, aging may affect ER function.
Most chronic diseases with tissue ﬁbrosis increase in incidence with
advanced age. Furthermore, there is evidence that the ER components
involved in protein folding are signiﬁcantly down-regulated with
age [99,100]. For example, in the kidney, BiP expression is reduced
in aged mice compared to young mice. With age, mice with heterozy-
gous deletion of BiP develop severe interstitial kidney injury with ﬁ-
brotic lesions and apoptosis of renal tubular cells mediated through
caspase-12 activation [73]. Taken together, it appears likely that mul-
tiple metabolic and environmental factors have the ability to induce
ER stress and activate UPR pathways. As individuals age, the cumula-
tive nature of these repeated insults may compound the effects of ER
stress. Furthermore, age related decrements in UPR responses may
impact the ability of cells to maintain homeostasis in the setting of
ER stress. In concert, these factors may, at least in part, explain why
ﬁbrotic diseases increase in incidence with aging. APOPTOSIS
Caspase 4/12,
CHOP 
Via PERK, ATF6, IRE1
EMT
Via IRE-1
Smad2/3 and Src
INFLAMMATION
Via IRE-1, XBP-1
ze &
echanisms
Loss of Epithelial Cells &
Fibroblast Activation
sis
may contribute to the development of pulmonary ﬁbrosis.
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In this review, we have provided evidence from recent studies of
lung, liver, GI tract, kidney, and heart that ER stress may play an im-
portant mechanistic component in the development and/or progres-
sion of tissue ﬁbrosis. We hypothesize that ER stress predisposes to
a vulnerable cell population, typically the epithelium, in many forms
of ﬁbrosis. In this setting, additional or repetitive exposure to injuri-
ous agents likely ignites a series of events that lead to progressive ﬁ-
brosis (Fig. 2). Many questions, however, remain unanswered related
to the mechanisms of ER stress induction and the speciﬁc means by
which the UPR pathway contributes to development of ﬁbrotic dis-
eases. An improved understanding of these mechanisms could lead
to new targeted therapies designed to alleviate the impact of ER stress
on critical cell populations and thus attenuate ﬁbrosis. However, as
we move forward, we must remember that the ER stress response
evolved to protect the cell and that attenuating UPR pathways could
have deleterious effects. As a result, future approaches designed to
improve protein processing or ameliorate the down-stream effects
of ER stress (like increased apoptosis) may actually be the best ave-
nues to pursue in targeting ER stress induced ﬁbrosis. Despite the cur-
rent gaps in knowledge, we remain hopeful that an improved
understanding of the functions of ER stress and UPR pathway activa-
tion in ﬁbrotic disorders will ultimately lead to new therapies for
these devastating diseases.
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